Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire

Table 1

Patient demographic data, lesion information, and comorbidity data.

Demographic data
Average age in years (median; range)	73.5 (76; 25–94)
Female	22 (50.0%)
Male	22 (50.0%)
Diagnoses
Basal cell carcinoma	22 (50.0%)
Squamous cell carcinoma	12 (27.3%)
Melanoma	7 (15.9%)
Dermatofibrosarcoma protuberans	1 (2.3%)
Merkel cell carcinoma	1 (2.3%)
Microcystic adnexal carcinoma	1 (2.3%)
Comorbidity data MI versus PRACE-27
	MI				PRACE-27
	0	1	2	3	0	1	2	3
Comorbid ailment
Myocardial infarction	43	1	—	—	40	2	2	—
Angina/coronary artery disease	38	6	—	—	37	5	2	—
Congestive heart failure	44	—	—	—	42	—	2	—
Arrhythmias	36	—	8	—	35	1	8	—
Hypertension	22	22	—	—	19	20	5	—
Venous disease	40	2	1	1	40	1	2	1
Peripheral arterial disease	44	—	—	—	42	—	2	—
Respiratory system	42	1	1	—	34	6	2	2
Hepatic	44	—	—	—	43	—	—	1
Stomach/intestine	44	—	—	—	44	—	—	—
Pancreas	44	—	—	—	44	—	—	—
End-stage renal disease	44	—	—	—	44	—	—	—
Diabetes mellitus	39	3	2	—	39	2	1	2
Stroke	39	3	2	—	37	6	1	—
Dementia	41	2	—	1	41	1	1	1
Paralysis	43	1	—	—	41	2	—	1
Neuromuscular	41	2	—	1	40	2	—	2
Psychiatric	42	2	—	—	42	1	1	—
Rheumatologic	44	—	—	—	43	1	—	—
AIDS	44	—	—	—	44	—	—	—
Solid tumor including melanoma	28	9	6	1	31	7	4	2
Leukemia and myeloma	42	1	1	—	42	1	1	—
Lymphoma	41	3	—	—	41	2	—	1
Alcohol	44	—	—	—	44	—	—	—
Illicit drugs	44	—	—	—	44	—	—	—
Obesity	44	—	—	—	41	—	3	—
Overall comorbidity score	9	16	12	7	5	13	13	13

The comorbidity data section compares the number of patients identified as having a comorbid ailment between the MI and PRACE-27. Individual organ systems and diseases were assessed based on specific criteria outlined by the grading guidelines on the following scale: 0 = no disease, grade 1 = mild decompensation, grade 2 = moderate decompensation, and grade 3 = severe decompensation. Based on the grading of these individual organ systems, an overall comorbidity score was calculated on a scale from 0 (no comorbidity) to 3 (severe comorbidity).